Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Medicine"
DOI: 10.1080/07853890.2022.2034936
Abstract: Abstract Background The coronavirus disease (COVID-19) epidemic has not been completely controlled. Although great achievements have been made in COVID-19 research and many antiviral drugs have shown good therapeutic effects against COVID-19, a simple oral…
read more here.
Keywords:
oral antiviral;
molnupiravir fluvoxamine;
covid;
covid patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Global Health Action"
DOI: 10.1080/16549716.2018.1433987
Abstract: ABSTRACT Background: Globally, of the 248 million people chronically infected with the hepatitis B virus (HBV), 74 million reside in China. Five oral nucleot(s)ide analogs (NUCs) have been approved for the treatment of chronic hepatitis…
read more here.
Keywords:
hepatitis;
oral antiviral;
chronic hepatitis;
therapy ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02479-20
Abstract: The impact of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of COVID-19, is global and unprecedented. Although remdesivir has recently been approved by the FDA to treat SARS-CoV-2 infection, no oral antiviral is…
read more here.
Keywords:
double prodrug;
treatment;
prodrug guanosine;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Saudi Medical Journal"
DOI: 10.15537/smj.2018.10.23056
Abstract: Objectives: To evaluate the histopathological changes in the liver after oral antiviral therapy in patients with chronic hepatitis B. Methods: A total of 79 HBeAg-negative and positive patients who had been on lamivudine, entecavir, or…
read more here.
Keywords:
antiviral therapy;
long term;
oral antiviral;
patients chronic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "MMWR. Morbidity and mortality weekly report"
DOI: 10.15585/mmwr.mm7125e1
Abstract: The COVID-19 pandemic has highlighted and exacerbated long-standing inequities in the social determinants of health (1-3). Ensuring equitable access to effective COVID-19 therapies is essential to reducing health disparities. Molnupiravir (Lagevrio) and nirmatrelvir/ritonavir (Paxlovid) are…
read more here.
Keywords:
vulnerability;
social vulnerability;
december 2021;
may 2022 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Viruses"
DOI: 10.3390/v14112540
Abstract: Despite the rapid development of efficient and safe vaccines against COVID-19, the need to confine the pandemic and treat infected individuals on an outpatient basis has led to the approval of oral antiviral agents. Taking…
read more here.
Keywords:
oral antiviral;
covid comprehensive;
covid;
antiviral treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "World Journal of Hepatology"
DOI: 10.4254/wjh.v9.i5.227
Abstract: Oral nucleoside/nucleotide analogues (NAs) are currently the backbone of chronic hepatitis B (CHB) infection treatment. They are generally well-tolerated by patients and safe to use. To date, a significant number of patients have been treated…
read more here.
Keywords:
antiviral therapy;
oral antiviral;
effects oral;
chronic hepatitis ... See more keywords